IAS 2017 Coverage

HIV/AIDS Amphotericin and Flucytosine Safe, Effective for HIV-Associated Cryptococcal Meningitis

Amphotericin and Flucytosine Safe, Effective for HIV-Associated Cryptococcal Meningitis

One-week amphotericin plus flucytosine was found to have comparable efficacy and safety profiles as the standard of care, 2-weeks amphotericin-based therapy, for treatment of HIV-associated cryptococcal meningitis in African patients.

HIV/AIDS Better Diagnostics Needed for Milder HIV-Associated Neurocognitive Disorders

Better Diagnostics Needed for Milder HIV-Associated Neurocognitive Disorders

In order to assess and manage milder forms of HIV-associated neurocognitive disorders, effective cognitive screening instruments are needed.

HIV/AIDS Efficacy of Crofelemer in Chronic HIV-Related Diarrhea Evaluated

Efficacy of Crofelemer in Chronic HIV-Related Diarrhea Evaluated

New findings announced from a supplemental analysis of Mytesi (crofelemer) in patients with HIV-related diarrhea.

HIV/AIDS Child Maintains HIV Remission Without ART Since 2008

Child Maintains HIV Remission Without ART Since 2008

A child who was diagnosed with HIV at 1 month and received early treatment has suppressed the virus without anti-HIV therapy for 8.5 years.

IAS 2017 New WHO Guidelines for Managing Pretreatment HIV Drug Resistance

New WHO Guidelines for Managing Pretreatment HIV Drug Resistance

New WHO guidelines address the issue of how to manage pretreatment human immunodeficiency virus drug resistance (HIVDR) in countries where the prevalence of HIVDR is 10% or higher.

IAS 2017 Long-Acting Injectable Antiretrovirals for HIV Effective and Safe

Long-Acting Injectable Antiretrovirals for HIV Effective and Safe

The combination of long-acting intramuscular cabotegravir plus rilpivirine was demonstrated to be as effective as 3-drug daily oral ART for maintaining viral suppression of HIV-1 for up to 96 weeks in the LATTE-2 phase 2b study.

IAS 2017 Dapivirine Vaginal Ring Safe and Acceptable Among Adolescent Girls

Dapivirine Vaginal Ring Safe and Acceptable Among Adolescent Girls

A new dapivirine vaginal ring was found to be safe and acceptable among adolescent girls in the United States.

IAS 2017 Efficacy, Safety of Fixed-Dose HIV Regimen With Bictegravir Evaluated

Efficacy, Safety of Fixed-Dose HIV Regimen With Bictegravir Evaluated

Gilead announced results from 2 Phase 3 studies for the investigational fixed-dose HIV regimen with bictegravir and emtricitabine for the treatment of treatment-naive adults with HIV.

IAS 2017 Early-Stage Trial for HIV Vaccine Shows Promise

Early-Stage Trial for HIV Vaccine Shows Promise

An early stage trial for HIV vaccine regimen was able to generate immune response against HIV.

Upcoming Meetings

Sign Up for Free e-newsletters